Treatment regimens, protocols, dosage, and indications for UVA1 phototherapy: facts and controversies.
about
Optimal management of fatigue in patients with systemic lupus erythematosus: a systematic review.Phototherapy, photodynamic therapy and photophoresis in the treatment of connective-tissue diseases: a review.UVA-1 laser: new device in phototherapeutic armamentarium of the dermatologist.UVA1 phototherapy in the treatment of palmoplantar pustulosis: a pilot prospective study.Fractional carbon dioxide laser versus low-dose UVA-1 phototherapy for treatment of localized scleroderma: a clinical and immunohistochemical randomized controlled study.Ultraviolet radiation and systemic lupus erythematosus.UVA irradiation induced heme oxygenase-1: a novel phototherapy for morphea.Ultraviolet A1 phototherapy beyond morphea: experience in 83 patients.German guidelines for the diagnosis and therapy of localized scleroderma.Quantitative assessment of photostability and photostabilisation of Fluvoxamine and its design for actinometry.A rare case of juvenile localised scleroderma with intra-oral and dental involvement.UVA1 a promising approach for scleroderma.Ultraviolet A-1 in Dermatological Diseases.A practical approach to the initial dose and subsequent increments for ultraviolet A1 phototherapy.European Dermatology Forum S1-guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 1: localized scleroderma, systemic sclerosis and overlap syndromes.Medium-dose ultraviolet A1 phototherapy improves SCORAD index and increases mRNA expression of interleukin-4 without direct effect on human β defensin-1, interleukin-10, and interleukin-31.UVA1 vs. narrowband UVB phototherapy in the treatment of palmoplantar pustulosis: a pilot randomized controlled study.Medium-dose ultraviolet A1 phototherapy and mRNA expression of TSLP, TARC, IL-5, and IL-13 in acute skin lesions in atopic dermatitis.Treatment of moderate and severe adult chronic atopic dermatitis with narrow-band UVB and the combination of narrow-band UVB/UVA phototherapy.Escalating dosimetry of UVA-1 in the treatment of alopecia areata.Ultraviolet A-1 phototherapy as an alternative for resistant alopecia areata.Altered global methylation and hydroxymethylation status in vulvar lichen sclerosus: further support for epigenetic mechanisms.The UV/Visible Radiation Boundary Region (385-405 nm) Damages Skin Cells and Induces "dark" Cyclobutane Pyrimidine Dimers in Human Skin in vivoUltraviolet A1 Phototherapy for Fibrosing ConditionsEffectiveness of acyclovir in the treatment of pityriasis rosea. A systematic review and meta-analysis
P2860
Q34351248-3928AF11-3E8C-41C9-8B5F-0ECA775BE53AQ35423702-950EB696-3C49-4658-AF9D-685358AA4E8DQ35667779-14B407FC-E3B6-4AEC-AFAC-70A11125248CQ36082721-CF69B89F-900D-41FC-B3B9-0C69E01E1E74Q36100604-FC4A71E8-3A86-497D-A882-1BF817FFD9CBQ38206950-127A17C6-58CC-4FE8-9908-E3700C4DC29DQ38248105-EA366CE0-100F-4D37-860D-BE919F91ADB6Q40860171-26E4B760-CD6E-4A92-99BF-6262544B9015Q40946338-EEB3F182-E937-4C14-AC35-EA2506F8C6AEQ41188725-F56C7B2B-89AB-4F84-B6F1-6633A5CEC9DAQ42092872-5E5DC192-F281-465F-87C5-B2DD1B6B8DDDQ42367920-0CA63DA2-D7EA-4922-8529-75658F9B3ED9Q47362748-2CF55232-89B8-411A-9FFD-15FEDE7DB601Q48088507-A6958A92-403F-47C5-9782-679F25CB93C5Q49072027-FAE6F80B-0B45-41D5-9641-FC19C95A571AQ50243026-2AD05630-DF20-4856-A74D-1B0222846A1CQ50247726-73B4F77C-7A6D-4189-AB66-F556039E5952Q50771690-1D164506-5D8A-4B2E-A291-580D82052AC0Q53368981-20D8C372-05A6-44F0-A05A-710CC4749F3CQ53716687-0524228F-C883-42D8-9CD0-B9FF4E783AD8Q53816775-AE9F4633-8913-4FD0-B393-269831F6C1B4Q54237885-43828FDB-2726-4F74-9FDD-8DF424A65EDBQ56918758-B2CD117D-DBAB-43B5-AFF0-C378B53BB7DDQ58700868-84C011C5-9580-419F-B2F6-4CC222FD219DQ58777641-41B46A94-8F90-49B3-BE8C-381525374C08
P2860
Treatment regimens, protocols, dosage, and indications for UVA1 phototherapy: facts and controversies.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Treatment regimens, protocols, ...... rapy: facts and controversies.
@en
type
label
Treatment regimens, protocols, ...... rapy: facts and controversies.
@en
prefLabel
Treatment regimens, protocols, ...... rapy: facts and controversies.
@en
P2093
P1476
Treatment regimens, protocols, ...... rapy: facts and controversies.
@en
P2093
Alexander Kreuter
Sarah Terras
Thilo Gambichler
P304
P356
10.1016/J.CLINDERMATOL.2013.01.011
P577
2013-07-01T00:00:00Z